Seller record · Telehealth service

Nucore Health

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: The site names no filling pharmacy. The program pages say prescriptions are fulfilled through trusted U.S. pharmacies, and the terms and privacy policy refer only to third-party pharmacies. 1 more criterion also fails; see the table below.

At a glance

Nucore HealthTelehealth service

6/8criteria passed
Price
Semaglutide from $179 a month, tirzepatide from $269
Sells
compounded semaglutide, compounded tirzepatide, and 7 more
FDA letters
None on file
Visit Nucore HealthSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth platform selling compounded semaglutide and tirzepatide injections, oral semaglutide and a microdose GLP-1 program, with NAD+, glutathione and sermorelin on its energy and anti-aging route. It names no filling pharmacy, and its only printed address is a Wilmington, Delaware registered-agent building.

Operating entity Nucore Technologies, LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSNucore Health's website; Nucore Health's GLP-1 treatments for weight loss page
S2Prescription gatingPASSNucore Health's intake site; Nucore Health's website; Nucore Health's nucore refund and cancellation policy openloop document
S3Pharmacy identificationFAILNucore Health's micro dosing page; Nucore Health's nucore terms of use openloop document
S4Compounding disclosurePASSNucore Health's GLP-1 treatments for weight loss page; Nucore Health's micro dosing page
S5Analytical documentationFAILNucore Health's GLP-1 treatments for weight loss page
S6Business addressPASSNucore Health's nucore terms of use openloop document; Nucore Health's nucore privacy policy openloop document
S7Price disclosurePASSNucore Health's GLP-1 treatments for weight loss page; Nucore Health's micro dosing page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed provider reviews each secure medical intake to determine eligibility, and a prescription ships only if approved.Source: Nucore Health's website; Nucore Health's GLP-1 treatments for weight loss page.
S2PASSEvery start button opens a separate intake site behind a security check, and the product pages carry no cart. The answers put the secure medical intake form before provider review, and the refund policy returns the first billing cycle when a provider finds the patient ineligible.Source: Nucore Health's intake site; Nucore Health's website; Nucore Health's nucore refund and cancellation policy openloop document.
S3FAILThe site names no filling pharmacy. The program pages say prescriptions are fulfilled through trusted U.S. pharmacies, and the terms and privacy policy refer only to third-party pharmacies.Source: Nucore Health's micro dosing page; Nucore Health's nucore terms of use openloop document.
S4PASSCompounded medications offered through NuCore Health have not been reviewed or approved by the FDA for safety, efficacy, or quality, printed on each program page, and the answers on every page state that compounded medications are not FDA-approved.Source: Nucore Health's GLP-1 treatments for weight loss page; Nucore Health's micro dosing page.
S5FAILNo certificate of analysis or lot document is published. The GLP-1 page says the compounding pharmacy conducts third-party quality testing, and no report is linked.Source: Nucore Health's GLP-1 treatments for weight loss page.
S6PASSNucore Technologies, LLC at Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware 19801, a registered-agent building, printed in the terms, the privacy policy, the refund policy and the telehealth consent.Source: Nucore Health's nucore terms of use openloop document; Nucore Health's nucore privacy policy openloop document.
S7PASSCompounded semaglutide as low as $179 a month, compounded tirzepatide as low as $269 and oral semaglutide as low as $209. The microdose program is as low as $199 a month, with an introductory offer of $69 for the first month and $169 for months two and three on a required 3-month purchase.Source: Nucore Health's GLP-1 treatments for weight loss page; Nucore Health's micro dosing page.
S8PASSNo FDA warning letter names Nucore Health or the operating entity Nucore Technologies, LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, oral compounded semaglutide, microdose GLP-1, NAD+, glutathione, sermorelin, MIC B12 and L-carnitine injections, hair restoration.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells glutathione

Unpaid link. Nucore Health does not pay the site, and nothing is earned when it is used. Funding.

Visit Nucore Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.